Literature DB >> 534968

Use of choline in the treatment of ataxia associated with multiple sclerosis.

R A Blattel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 534968      PMCID： PMC1704645     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  3 in total

1.  Lecithin in Alzheimer's disease.

Authors:  P Etienne; S Gauthier; D Dastoor; B Collier; J Ratner
Journal:  Lancet       Date:  1978-12-02       Impact factor: 79.321

2.  Oral choline in cerebellar ataxia.

Authors:  N J Legg
Journal:  Br Med J       Date:  1978-11-18

3.  Lecithin can suppress tardive dyskinesia.

Authors:  J H Growdon; A J Gelenberg; J Doller; M J Hirsch; R J Wurtman
Journal:  N Engl J Med       Date:  1978-05-04       Impact factor: 91.245
  3 in total
  3 in total

Review 1.  Potential Therapeutic Application for Nicotinic Receptor Drugs in Movement Disorders.

Authors:  Maryka Quik; James T Boyd; Tanuja Bordia; Xiomara Perez
Journal:  Nicotine Tob Res       Date:  2019-02-18       Impact factor: 4.244

2.  Neuronal nicotinic receptor agonists improve gait and balance in olivocerebellar ataxia.

Authors:  L Wecker; M E Engberg; R M Philpot; C S Lambert; C W Kang; J C Antilla; P C Bickford; C E Hudson; T A Zesiewicz; Peter P Rowell
Journal:  Neuropharmacology       Date:  2013-05-24       Impact factor: 5.250

Review 3.  Role for the nicotinic cholinergic system in movement disorders; therapeutic implications.

Authors:  Maryka Quik; Danhui Zhang; Xiomara A Perez; Tanuja Bordia
Journal:  Pharmacol Ther       Date:  2014-05-14       Impact factor: 12.310
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.